ArticleCellular oncology (Dordrecht, Netherlands)2021

AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.

Caterina Peraldo-Neia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.